目的评估氨磺必利片治疗精神分裂症急性发作患者的疗效和安全性。方法根据ICD-10精神分裂症的诊断标准，纳入急性发作患者144例，给予可调节剂量氨磺必利片单药治疗8周；治疗初始剂量为200 mg/d，依据患者的临床状况调节氨磺必利片的剂...目的评估氨磺必利片治疗精神分裂症急性发作患者的疗效和安全性。方法根据ICD-10精神分裂症的诊断标准，纳入急性发作患者144例，给予可调节剂量氨磺必利片单药治疗8周；治疗初始剂量为200 mg/d，依据患者的临床状况调节氨磺必利片的剂量，推荐治疗量为800 mg/d，最大剂量为1 200 mg/d。分别于基线、治疗第2、4、8周采用PANSS，于基线及治疗第8周采用临床总体印象量表-严重程度和总体改善（CGI-S, CGI-I）、个人与社会功能量表（Personal and Social Performance Scale,PSP）评估临床疗效；采用UKU（Udvalg for Kliniske Undersogeser）不良反应评估量表、血生化指标和心电图等评估治疗的安全性。分别采用符合方案和安全性数据集分析氨磺必利片的疗效和安全性。结果共132例完成临床研究，脱落12例；经8周治疗，急性发作精神分裂症患者PANSS阳性症状分[（22.0±6.6）分与（10.0±3.8）分]、阴性症状分[（22.7±7.7）分与（13.9±6.8）分]、一般精神病理分[（41.6±9.0）分与（25.1±7.4）分]、总分[（86.5±16.0）分与（49.0±16.0）分]均显著降低（均P〈0.01）；PANSS总分有效率（PANSS总分减分率≥50%）为77.3%（102/132），CGI-I有效率为75.8%（100/132）；阳性症状亚组PANSS总分有效率优于阴性症状亚组（χ^2=9.52，P〈0.01）；经8周治疗，个人与社会表现量表总分显著提高（t=18.10，P〈0.01）；不良反应主要为锥体外系不良反应（29.2%）和催乳素升高（23.6%）。结论氨磺必利片可有效缓解精神分裂症急性发作患者的精神病理症状，最常见的不良反应为锥体外系不良反应和泌乳素升高，未见其他抗精神病药未发生的不良反应。展开更多
The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of ...The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in June 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in June 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.展开更多
The mercury removals by existing pollution control devices and the mass balances of mercury in four coal-fired power plants of China were carried out based on a measurement method with the aluminum matrix sorbent.All ...The mercury removals by existing pollution control devices and the mass balances of mercury in four coal-fired power plants of China were carried out based on a measurement method with the aluminum matrix sorbent.All the plants are equipped with a cold-side electrostatic precipitator （ESP） and a wet flue gas desulfurization （FGD） in series.During the course of coal stream,the samples,such as coal,bottom ash,fly ash,gypsum and flue gas,were collected.The Hg concentrations in coals were measured by CVAAS after appropriate preparation and acid digestion.Other solid samples were measured by the RA-915 ＋ Zeeman Mercury Spectrometer.The vapor phase Hg was collected by a sorbent trap from flue gas and then measured using CVAAS followed by acid leaching.The mercury mass balances were estimated in this study were 91.6%,77.1%,118% and 85.8% for the four power plants,respectively.The total Hg concentrations in the stack gas were ranged from 1.56–5.95 μg/m 3.The relative distribution of Hg in bottom ash,ESP,WFGD and stack discharged were ranged between 0.110%–2.50%,2.17%–23.4%,2.21%–87.1%,and 21.8%–72.7%,respectively.The distribution profiles were varied with the coal type and the operation conditions.The Hg in flue gas could be removed by ESP and FGD systems with an average removal efficiency of 51.8%.The calculated average emission factor was 0.066 g/ton and much lower than the results obtained ten years ago.展开更多
Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are limited.The aim of the present study was to investigate the prevalence,awareness,treatment,and co...Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are limited.The aim of the present study was to investigate the prevalence,awareness,treatment,and control of hypertension in the non-dialysis CKD patients through a nationwide,multicenter study in China.Methods The survey was performed in 61 tertiary hospitals in 31 provinces,municipalities,and autonomous regions in China （except Hong Kong,Macao,and Taiwan）.Trained physicians collected demographic and clinical data and measured blood pressure （BP） using a standardized protocol.Hypertension was defned as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg,and/or use of antihypertensive medications.BP 〈140/90 mmHg and 〈130/80 mmHg were used as the 2 thresholds of hypertension control.In multivariate logistic regression with adjustment for sex and age,we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD patients.Results The analysis included 8927 non-dialysis CKD patients.The prevalence,awareness,and treatment of hypertension in non-dialysis CKD patients were 67.3%,85.8%,and 81.0%,respectively.Of hypertensive CKD patients,33.1% and 14.1% had controlled BP to 〈140/90 mmHg and 〈130/80 mmHg,respectively.With successive CKD stages,the prevalence of hypertension in non-dialysis CKD patients increased,but the control of hypertension decreased （P〈0.001）.When the threshold of BP 〈130/80 mmHg was considered,the risk of uncontrolled hypertension in CKD 2,3a,3b,4,and 5 stages increased 1.3,1.4,1.4,2.5,and 4.0 times compared with CKD 1 stage,respectively （P〈0.05）.Using the threshold of 〈140/90 mmHg,the risk of uncontrolled hypertension increased in advanced stages （P〈0.05）.Conclusions The prevalence of hypertension Chinese non-dialysis CKD patients was high,and the hypertension control was suboptimal.With successive CKD stages,the risk of uncontrolled hypertension increased.展开更多
AIM： To investigate the effect of shenfu injection on gastrointestinal microcirculation after myocardial ischemic-reperfusion （IR） injury in rabbits and probe into the mechanism. METHODS： Forty healthy flap-eared ...AIM： To investigate the effect of shenfu injection on gastrointestinal microcirculation after myocardial ischemic-reperfusion （IR） injury in rabbits and probe into the mechanism. METHODS： Forty healthy flap-eared white rabbits were randomly divided into 4 groups： IR injury control group （group Ⅰ ）, shenfu injection 5 mL/kg per h group （group Ⅱ）, shenfu injection 10 mL/kg per h group （group Ⅲ） and shenfu injection 20 mL/kg per h group （group Ⅳ）. The four groups were treated with Lactated Ringer＇s solution, shenfu injection 5, 10, and 20 mL/ kg per h were infused intravenously 30 min before experiment respectively. The values of hemodynamics [mean arterial pressure （MAP）, heart rate （HR）, gastric intramucosal partial pressure of carbon dioxide （PCO2）, blood gas analysis and pH] were measured and compared with those before myocardial ischemia, 60 min after myocardial ischemia and 60, 90, and 180 rain after reperfusion. RESULTS： The MAP, HR and gastric intramucosal pH were （70.50 ± 4.50） kPa, （165 ± 14） beats per rain, 7.032 ± 0.024 in group Ⅰ 60 min after myocardial ischemia, which were significantly decreased compared with those before myocardial ischemia （88.50 ± 9.75 kPa, 217 ± 18 beats per rain, 7.112 ± 0.035, P 〈 0.05）. The MAP, HR and gastric intramucosal pH were significantly decreased in group Ⅰ 60, 90, and 180 min after reperfusion （61.50 ± 5.25 kPa, 133 ± 31 beats per rain, 6.997 ± 0.025） compared with those before reperfusion respectively （P 〈 0.05）, whereas the values were insignificantly different in groups Ⅱ, Ⅲ or Ⅳ after reperfusion, compared with those before reperfusion, and there were no significant differences between groups Ⅱ, Ⅲ, and Ⅳ after reperfusion. CONCLUSION： Pre-infusion of shenfu injection has a protective effect on gastrointestinal microcirculation after myocardial IR injury in rabbits, in a dose independent manner.展开更多
AIM To evaluate the effectiveness and safety of submucosal tunneling endoscopic resection(STER) and compare its outcomes in esophageal and cardial submucosal tumors(SMTs) of the muscularis propria(MP) layer.METHODS Fr...AIM To evaluate the effectiveness and safety of submucosal tunneling endoscopic resection(STER) and compare its outcomes in esophageal and cardial submucosal tumors(SMTs) of the muscularis propria(MP) layer.METHODS From May 2012 to November 2017, 173 consecutive patients with upper gastrointestinal(GI) SMTs of the MP layer underwent STER. Overall, 165 patients were included, and 8 were excluded. The baseline characteristics of the patients and SMTs were recorded. The en bloc resection rate, complete resection rate,residual rate, and recurrence rate were calculated to evaluate the effectiveness of STER, and the complication rate was recorded to evaluate its safety. Effectiveness and safety outcomes were compared between esophageal and cardial SMTs.RESULTS One hundred and twelve men and 53 women with a mean age of 46.9 ± 10.8 years were included. The mean tumor size was 22.6 ± 13.6 mm. Eleven SMTs were located in the upper esophagus(6.7%), 49 in the middle esophagus(29.7%), 46 in the lower esophagus(27.9%), and 59 in the cardia(35.7%). Irregular lesions accounted for 48.5% of all lesions. STER achieved an en bloc resection rate of78.7%(128/165) for GI SMTs with an overall complication rate of 21.2%(35/165).All complications resolved without intervention or were treated conservatively without the need for surgery. The en bloc resection rates of esophageal and cardial SMTs were 81.1%(86/106) and 72.1%(42/59), respectively(P = 0.142), and the complication rates were 19.8%(21/106) and 23.7%(14/59), respectively,(P =0.555). The most common complications for esophageal SMTs were gas-related complications and fever, while mucosal injury was the most common for cardial SMTs.CONCLUSION STER is an effective and safe therapy for GI SMTs of the MP layer. Its effectiveness and safety are comparable between SMTs of the esophagus and cardia.展开更多
文摘目的评估氨磺必利片治疗精神分裂症急性发作患者的疗效和安全性。方法根据ICD-10精神分裂症的诊断标准，纳入急性发作患者144例，给予可调节剂量氨磺必利片单药治疗8周；治疗初始剂量为200 mg/d，依据患者的临床状况调节氨磺必利片的剂量，推荐治疗量为800 mg/d，最大剂量为1 200 mg/d。分别于基线、治疗第2、4、8周采用PANSS，于基线及治疗第8周采用临床总体印象量表-严重程度和总体改善（CGI-S, CGI-I）、个人与社会功能量表（Personal and Social Performance Scale,PSP）评估临床疗效；采用UKU（Udvalg for Kliniske Undersogeser）不良反应评估量表、血生化指标和心电图等评估治疗的安全性。分别采用符合方案和安全性数据集分析氨磺必利片的疗效和安全性。结果共132例完成临床研究，脱落12例；经8周治疗，急性发作精神分裂症患者PANSS阳性症状分[（22.0±6.6）分与（10.0±3.8）分]、阴性症状分[（22.7±7.7）分与（13.9±6.8）分]、一般精神病理分[（41.6±9.0）分与（25.1±7.4）分]、总分[（86.5±16.0）分与（49.0±16.0）分]均显著降低（均P〈0.01）；PANSS总分有效率（PANSS总分减分率≥50%）为77.3%（102/132），CGI-I有效率为75.8%（100/132）；阳性症状亚组PANSS总分有效率优于阴性症状亚组（χ^2=9.52，P〈0.01）；经8周治疗，个人与社会表现量表总分显著提高（t=18.10，P〈0.01）；不良反应主要为锥体外系不良反应（29.2%）和催乳素升高（23.6%）。结论氨磺必利片可有效缓解精神分裂症急性发作患者的精神病理症状，最常见的不良反应为锥体外系不良反应和泌乳素升高，未见其他抗精神病药未发生的不良反应。
基金funded by the National Basic Research Program of China (973 Program, 2014CB845700)the National Natural Science Foundation of China (Grant Nos. 11390371)Funding for the project has been provided by the National Development and Reform Commission
文摘The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in June 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in June 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.
基金supported by the National High-Tech Research and Development Program (863) of China(No.2007AA06Z340)
文摘The mercury removals by existing pollution control devices and the mass balances of mercury in four coal-fired power plants of China were carried out based on a measurement method with the aluminum matrix sorbent.All the plants are equipped with a cold-side electrostatic precipitator （ESP） and a wet flue gas desulfurization （FGD） in series.During the course of coal stream,the samples,such as coal,bottom ash,fly ash,gypsum and flue gas,were collected.The Hg concentrations in coals were measured by CVAAS after appropriate preparation and acid digestion.Other solid samples were measured by the RA-915 ＋ Zeeman Mercury Spectrometer.The vapor phase Hg was collected by a sorbent trap from flue gas and then measured using CVAAS followed by acid leaching.The mercury mass balances were estimated in this study were 91.6%,77.1%,118% and 85.8% for the four power plants,respectively.The total Hg concentrations in the stack gas were ranged from 1.56–5.95 μg/m 3.The relative distribution of Hg in bottom ash,ESP,WFGD and stack discharged were ranged between 0.110%–2.50%,2.17%–23.4%,2.21%–87.1%,and 21.8%–72.7%,respectively.The distribution profiles were varied with the coal type and the operation conditions.The Hg in flue gas could be removed by ESP and FGD systems with an average removal efficiency of 51.8%.The calculated average emission factor was 0.066 g/ton and much lower than the results obtained ten years ago.
文摘Background Data on the epidemiology of hypertension in Chinese non-dialysis chronic kidney disease （CKD） patients are limited.The aim of the present study was to investigate the prevalence,awareness,treatment,and control of hypertension in the non-dialysis CKD patients through a nationwide,multicenter study in China.Methods The survey was performed in 61 tertiary hospitals in 31 provinces,municipalities,and autonomous regions in China （except Hong Kong,Macao,and Taiwan）.Trained physicians collected demographic and clinical data and measured blood pressure （BP） using a standardized protocol.Hypertension was defned as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg,and/or use of antihypertensive medications.BP 〈140/90 mmHg and 〈130/80 mmHg were used as the 2 thresholds of hypertension control.In multivariate logistic regression with adjustment for sex and age,we analyzed the association between CKD stages and uncontrolled hypertension in non-dialysis CKD patients.Results The analysis included 8927 non-dialysis CKD patients.The prevalence,awareness,and treatment of hypertension in non-dialysis CKD patients were 67.3%,85.8%,and 81.0%,respectively.Of hypertensive CKD patients,33.1% and 14.1% had controlled BP to 〈140/90 mmHg and 〈130/80 mmHg,respectively.With successive CKD stages,the prevalence of hypertension in non-dialysis CKD patients increased,but the control of hypertension decreased （P〈0.001）.When the threshold of BP 〈130/80 mmHg was considered,the risk of uncontrolled hypertension in CKD 2,3a,3b,4,and 5 stages increased 1.3,1.4,1.4,2.5,and 4.0 times compared with CKD 1 stage,respectively （P〈0.05）.Using the threshold of 〈140/90 mmHg,the risk of uncontrolled hypertension increased in advanced stages （P〈0.05）.Conclusions The prevalence of hypertension Chinese non-dialysis CKD patients was high,and the hypertension control was suboptimal.With successive CKD stages,the risk of uncontrolled hypertension increased.
文摘AIM： To investigate the effect of shenfu injection on gastrointestinal microcirculation after myocardial ischemic-reperfusion （IR） injury in rabbits and probe into the mechanism. METHODS： Forty healthy flap-eared white rabbits were randomly divided into 4 groups： IR injury control group （group Ⅰ ）, shenfu injection 5 mL/kg per h group （group Ⅱ）, shenfu injection 10 mL/kg per h group （group Ⅲ） and shenfu injection 20 mL/kg per h group （group Ⅳ）. The four groups were treated with Lactated Ringer＇s solution, shenfu injection 5, 10, and 20 mL/ kg per h were infused intravenously 30 min before experiment respectively. The values of hemodynamics [mean arterial pressure （MAP）, heart rate （HR）, gastric intramucosal partial pressure of carbon dioxide （PCO2）, blood gas analysis and pH] were measured and compared with those before myocardial ischemia, 60 min after myocardial ischemia and 60, 90, and 180 rain after reperfusion. RESULTS： The MAP, HR and gastric intramucosal pH were （70.50 ± 4.50） kPa, （165 ± 14） beats per rain, 7.032 ± 0.024 in group Ⅰ 60 min after myocardial ischemia, which were significantly decreased compared with those before myocardial ischemia （88.50 ± 9.75 kPa, 217 ± 18 beats per rain, 7.112 ± 0.035, P 〈 0.05）. The MAP, HR and gastric intramucosal pH were significantly decreased in group Ⅰ 60, 90, and 180 min after reperfusion （61.50 ± 5.25 kPa, 133 ± 31 beats per rain, 6.997 ± 0.025） compared with those before reperfusion respectively （P 〈 0.05）, whereas the values were insignificantly different in groups Ⅱ, Ⅲ or Ⅳ after reperfusion, compared with those before reperfusion, and there were no significant differences between groups Ⅱ, Ⅲ, and Ⅳ after reperfusion. CONCLUSION： Pre-infusion of shenfu injection has a protective effect on gastrointestinal microcirculation after myocardial IR injury in rabbits, in a dose independent manner.
基金Supported by the National Program on Key Research Project(13-5 Program),No.2016YFC1303601Chinese PLA General Hospital Clinical Research,No.2012FC-TSYS-3035
文摘AIM To evaluate the effectiveness and safety of submucosal tunneling endoscopic resection(STER) and compare its outcomes in esophageal and cardial submucosal tumors(SMTs) of the muscularis propria(MP) layer.METHODS From May 2012 to November 2017, 173 consecutive patients with upper gastrointestinal(GI) SMTs of the MP layer underwent STER. Overall, 165 patients were included, and 8 were excluded. The baseline characteristics of the patients and SMTs were recorded. The en bloc resection rate, complete resection rate,residual rate, and recurrence rate were calculated to evaluate the effectiveness of STER, and the complication rate was recorded to evaluate its safety. Effectiveness and safety outcomes were compared between esophageal and cardial SMTs.RESULTS One hundred and twelve men and 53 women with a mean age of 46.9 ± 10.8 years were included. The mean tumor size was 22.6 ± 13.6 mm. Eleven SMTs were located in the upper esophagus(6.7%), 49 in the middle esophagus(29.7%), 46 in the lower esophagus(27.9%), and 59 in the cardia(35.7%). Irregular lesions accounted for 48.5% of all lesions. STER achieved an en bloc resection rate of78.7%(128/165) for GI SMTs with an overall complication rate of 21.2%(35/165).All complications resolved without intervention or were treated conservatively without the need for surgery. The en bloc resection rates of esophageal and cardial SMTs were 81.1%(86/106) and 72.1%(42/59), respectively(P = 0.142), and the complication rates were 19.8%(21/106) and 23.7%(14/59), respectively,(P =0.555). The most common complications for esophageal SMTs were gas-related complications and fever, while mucosal injury was the most common for cardial SMTs.CONCLUSION STER is an effective and safe therapy for GI SMTs of the MP layer. Its effectiveness and safety are comparable between SMTs of the esophagus and cardia.
